| fluvastatin / Generic mfg. |
2004-003235-31: Effect of pravastatin or fluvastatin and add-on valsartan on inflammatory markers and peripheral endothelial function in patients with acute coronary syndrome |
|
|
| Ongoing | 4 | 80 | Europe | Lescol, Diovan, PRAVASTATIN "RATIOPHARM", Tablet, Lescol, Diovan, PRAVASTATIN "RATIOPHARM" | Div. of Cardiology, Innsbruck Medical University | Acute coronary syndrome; patients with NSTEMI | | | | |
| Completed | 4 | 200 | | Fluvastatin 80mg every night, oral intake ;Atorvastatin 20mg every night, oral intake | Department of cardiology in the First Hospital of Nanjing; Level of the institution：, Self-financing | Coronary heart disease | | | | |
ChiCTR-TRC-12002642: Upstream Therapeutic Strategies of Valsartan and Fluvastatin on Hypertension Patients with Non-chronic Atrial Fibrillation |
|
|
| Completed | 4 | 2000 | | Valsartan ;fluvastatin & CCB ;valsartan & fluvastatin ;CCB | The second hospital of Tianjin Medical University; Level of the institution：, Unit self-finance, financial appropriation | Hypertension Patients with Atrial Fibrillation | | | | |
2008-005147-42: Arteriosclerosis y Lupus Eritematoso Sistémico: ¿Pueden las Estatinas detener este proceso? |
|
|
| Ongoing | 4 | 125 | Europe | Fluvastatina, | Mª Angeles Aguirre Zamorano | Prevención primaria del desarrollo de arteriosclerosis precoz en pacientes con Lupus Eritematoso Sistémico. | | | | |
2011-001055-36: Randomized controlled clinical trial phase IV to validate a cost-effective tool to optimize statin treatment of diabetic dyslipidemia in primary care |
|
|
| Ongoing | 4 | 28 | Europe | Simvastatina, Atorvastatina, Rosuvastatina, Ezetimiba, Fluvastatina sodica, Pravastatina, Simvastatina, Atorvastatina, Rosuvastatina, Ezetimiba, Fluvastatina sodica, Pravastatina, Simvastatina, Atorvastatina, Rosuvastatina, Ezetimiba, Fluvastatina sodica, Pravastatina | Eduardo García Díaz, Eduardo García Díaz | Diabetes and cardiovascular events Diabetes y eventos carrdiovasculares | | | | |
2009-011291-29: RACE 3 study: Intensive vs. usual rhythm control for atrial fibrillation. |
|
|
| Ongoing | 4 | 250 | Europe | eplerenone, Spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin, eplerenone, spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin, eplerenone, spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin | Interuniversity Cardiology Institute of the Netherlands (ICIN), Interuniversity Cardiology Institute Netherlands, The Interuniversity Cardiology Institute of the Netherlands (ICIN), Netherlands Heart Foundation (NHS B 2008 035), Working group on Cardiovascular Research, the Netherlands, Sanofi Aventis, Boehringer Ingelheim, Medtronic, Biotronik, St Jude Medical, Boston Scientific, AstraZenenca, Interuniversity Cardiology Institute Netherlands, Working group on Cardiovascular Research, Astra Zeneca, Bayer | atrial fibrillation | | | | |
PREVESTATGx, NCT06262685: Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins |
|
|
| Not yet recruiting | 4 | 216 | Europe | Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic simvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelines, Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pravastatin dose based on CPIC guidelines, Preemptive pharmacogenetic lovastatin dose based on CPIC guidelines, Preemptive pharmacogenetic fluvastatin dose based on CPIC guidelines, Standard of Care (SoC) dosing of atorvastatin, Standard of Care (SoC) dosing of simvastatin, Standard of Care (SoC) dosing of pitavastatin, Standard of Care (SoC) dosing of rosuvastatin, Standard of Care (SoC) dosing of prasavastatin, Standard of Care (SoC) dosing of lovastatin, Standard of Care (SoC) dosing of fluvastatin | Instituto de Investigación Hospital Universitario La Paz, Instituto de Salud Carlos III | Cardiovascular Diseases, Dyslipidemias, Statin Adverse Reaction, Pharmacogenic Myopathy | 02/25 | 03/25 | | |
| Ongoing | 3 | 70 | Europe | Lescol, Lescol 28 cps 20mg, C10AA04 - FLUVASTATINA FLUVASTATINA SODICA LESCOL*28CPR 80MG R.P., C10AA04 - FLUVASTATINA FLUVASTATINA SODICA LESCOL*28CPS 20MG, C10AA04 - FLUVASTATINA FLUVASTATINA SODICA LESCOL*28CPR 80MG R.P., C10AA04 - FLUVASTATINA FLUVASTATINA SODICA LESCOL*28CPS 20MG | AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | non disponibile | | | | |
ChiCTR2200059623: A Multicenter, Randomized, Controlled, Double-Blind Phase III Study of BEBT-209 in Combination with Fulvestrant Versus Placebo in Combination with Fulvestrant in HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Have Progressed on Prior Endocrine Therapy |
|
|
| Not yet recruiting | 3 | 330 | | Oral BEBT-209 and intramuscular fluvastatin; Oral placebo and intramuscular fluvastatin | Cancer Hospital Chinese Academy of Medical Sciences; BeBetter Med Inc., BeBetter Med Inc. | HR-positive, HER2-negative locally advanced or metastatic breast cancer | | | | |
2006-006588-21: Fluvastatin as adjuvant therapy to alfa-interferon and ribavirin in the treatment of chronic hepatitis C in patients with HIV-1 coinfection |
|
|
| Ongoing | 2 | 76 | Europe | LESCOL, LESCOL | AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) | Chronic hepatitis C in HIV/HCV coinfection | | | | |
2006-004335-29: A randomised controlled factorial pilot study investigating Omacor and/or Fluvastatin in patients with chronic hepatitis C who have not responded to standard combination anti-viral therapy. |
|
|
| Ongoing | 2 | 72 | Europe | Omacor, Lescol, Omacor, Lescol | Newcastle Upon Tyne Hospitals NHS Foundation Trust | Chronic Hepatitis C Infection | | | | |
ACTRN12612000136808: Phase I study of RAD001 (Everolimus) in combination with Fluvastatin and Zoledronic acid in patients with solid tumours |
|
|
| Active, not recruiting | 1 | 25 | | | St George Hospital, Novartis Pharmaceuticals Australia Pty Ltd | Advanced cancers | | | | |
| Completed | 1 | 40 | | oral ingestion of a single dose of fluvastatin sodium capsules ;oral ingestion of a single dose of fluvastatin sodium capsules (Lescol) | The 2nd Affiliated Hospital, School of Medicine, Zhejiang University; Level of the institution：, Zhejiang Haizheng Pharma Co. Ltd. | not disease-related | | | | |
ChiCTR-TTRCC-12002290: Investigations on relations between SNPs in statin-related transporters and metabolizing enzymes and pharmacokinetics of fluvastatin, simvastatin, rosuvastatin and pitavastatin |
|
|
| Completed | 1 | 64 | | Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying ;Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying ;Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying ;Retrospective analysis of pharmacokinetics data and collect 5ml blood for genotying | The 2nd Affiliated Hospital, School of Medicine, Zhejiang University; The Second Affiliated Hospital， School of Medicine，Zhejiang University, Division of Clinical Pharmacology, The 2nd Affiliated Hospital, School of Medicine, Zhejiang University | not disease-related | | | | |
ChiCTR-TQR-12002602: The Effects of an Combinedative Treatment of with Prednisone plus and Fluvastatin on the Levels of Cholesterol and Bilirubin in the Patients with Minimal Change Nephropathy |
|
|
| Completed | 1 | 60 | | prednisone 1~2 mg/kg/day+Fluvastatin Sodium Capsule ;prednisone 1~2 mg/kg/day | Treatment center of kidney disease, 281th hospital of PLA; Level of the institution：, Hospital funded | Minimal change nephrotic syndrome in children | | | | |
ChiCTR-ORC-16008705: Fluvastatin combined with benazepril may contribute to favorable prognosis of auricular fibrillation |
|
|
| Recruiting | N/A | 92 | | fluvastatin + benazepril ;fluvastatin | the First Affiliated Hospital of Harbin Medical University; the First Affiliated Hospital of Harbin Medical University, Department of Health of Heilongjiang Province GC12C305-6 | Auricular Fibrillation | | | | |
